← Eichor
Study identifier: NCT06430359 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Circadian Variation of Urinary Copper Excretion in Wilson Disease Patients

Condition: Wilson Disease  ·  Sponsor: Hospices Civils de Lyon

PhaseN/A
Planned participants30
Who can joinAll sexes, 6 Years to 70 Years
Healthy volunteersNo

About this study

Wilson's disease (WD) is a genetic disorder characterized by an accumulation of copper in the body, mainly in the liver and brain. Patients suffering from this disease are monitored by liver function tests, blood copper levels, and 24-hour urinary copper determinations. Treatment is based either on chelating the copper accumulated in the body using D-penicillamine or Trientine or on limiting intestinal copper absorption with zinc salts. Monitoring copper elimination in urine collected over 24 hours is essential for estimating a patient's copper load, adapting treatment dosage, and detecting any copper deficiency. Nevertheless, urine collection is often complicated for patients, given the obvious constraints of collecting urine over 24 hours. Without this, clinical decisions are usually made based on spot urine. There is no official recommendation for monitoring urinary copper elimination other than on 24-hour urine. According to studies on healthy volunteers under physiological conditions, urinary copper elimination occurs according to a circadian rhythm, with minimal copper elimination between 8 pm and 4 am and maximum between 8 am and noon. The study would aim to find the period of the day best correlated with 24h urinary copper excretion

This description comes directly from the study's public registry record.

Talk to the study team

Eduardo COUCHONNAL, Dr  ·  04 27 35 70 50  ·  eduardo.couchonnal-bedoya@chu-lyon.fr

Abdelouahed BELMALIH, PhD  ·  04 27 85 62 67  ·  abdelouahed.belmalih@chu-lyon.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Service de Gastroentérologie, Hépatologie et Nutrition Pédiatriques - Hôpital Femme Mère EnfantBron, Rhone, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06430359